CORE LABORATORIES INC (CLB) Fundamental Analysis & Valuation

NYSE:CLB • US21867A1051

Current stock price

15.889 USD
-0.17 (-1.06%)
Last:

This CLB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CLB Profitability Analysis

1.1 Basic Checks

  • In the past year CLB was profitable.
  • CLB had a positive operating cash flow in the past year.
  • Each year in the past 5 years CLB has been profitable.
  • In the past 5 years CLB always reported a positive cash flow from operatings.
CLB Yearly Net Income VS EBIT VS OCF VS FCFCLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.33%, CLB is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • CLB has a better Return On Equity (11.37%) than 76.67% of its industry peers.
  • With a decent Return On Invested Capital value of 8.59%, CLB is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CLB is significantly below the industry average of 13.36%.
  • The last Return On Invested Capital (8.59%) for CLB is above the 3 year average (8.28%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.33%
ROE 11.37%
ROIC 8.59%
ROA(3y)5.63%
ROA(5y)4.73%
ROE(3y)13.38%
ROE(5y)12.66%
ROIC(3y)8.28%
ROIC(5y)7.52%
CLB Yearly ROA, ROE, ROICCLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

1.3 Margins

  • CLB's Profit Margin of 6.04% is fine compared to the rest of the industry. CLB outperforms 66.67% of its industry peers.
  • In the last couple of years the Profit Margin of CLB has grown nicely.
  • CLB's Operating Margin of 11.38% is in line compared to the rest of the industry. CLB outperforms 60.00% of its industry peers.
  • CLB's Operating Margin has declined in the last couple of years.
  • The Gross Margin of CLB (20.69%) is worse than 66.67% of its industry peers.
  • In the last couple of years the Gross Margin of CLB has declined.
Industry RankSector Rank
OM 11.38%
PM (TTM) 6.04%
GM 20.69%
OM growth 3Y6.08%
OM growth 5Y-2.63%
PM growth 3Y14.9%
PM growth 5YN/A
GM growth 3Y1.78%
GM growth 5Y-2.17%
CLB Yearly Profit, Operating, Gross MarginsCLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

5

2. CLB Health Analysis

2.1 Basic Checks

  • CLB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for CLB has been reduced compared to 1 year ago.
  • Compared to 5 years ago, CLB has more shares outstanding
  • Compared to 1 year ago, CLB has an improved debt to assets ratio.
CLB Yearly Shares OutstandingCLB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
CLB Yearly Total Debt VS Total AssetsCLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • The Debt to FCF ratio of CLB is 4.88, which is a neutral value as it means it would take CLB, 4.88 years of fcf income to pay off all of its debts.
  • CLB has a Debt to FCF ratio (4.88) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.39 indicates that CLB is not too dependend on debt financing.
  • The Debt to Equity ratio of CLB (0.39) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.88
Altman-Z N/A
ROIC/WACC1.06
WACC8.11%
CLB Yearly LT Debt VS Equity VS FCFCLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

  • CLB has a Current Ratio of 2.07. This indicates that CLB is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.07, CLB is in the better half of the industry, outperforming 63.33% of the companies in the same industry.
  • A Quick Ratio of 1.57 indicates that CLB should not have too much problems paying its short term obligations.
  • CLB has a Quick ratio (1.57) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 1.57
CLB Yearly Current Assets VS Current LiabilitesCLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

4

3. CLB Growth Analysis

3.1 Past

  • CLB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.64%.
  • The Earnings Per Share has been decreasing by -0.77% on average over the past years.
  • Looking at the last year, CLB shows a small growth in Revenue. The Revenue has grown by 0.51% in the last year.
  • CLB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.56% yearly.
EPS 1Y (TTM)-13.64%
EPS 3Y9.43%
EPS 5Y-0.77%
EPS Q2Q%-4.55%
Revenue 1Y (TTM)0.51%
Revenue growth 3Y2.45%
Revenue growth 5Y1.56%
Sales Q2Q%6.98%

3.2 Future

  • CLB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.48% yearly.
  • CLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.42% yearly.
EPS Next Y-0.77%
EPS Next 2Y2.53%
EPS Next 3Y21.51%
EPS Next 5Y20.48%
Revenue Next Year-0.76%
Revenue Next 2Y-0.67%
Revenue Next 3Y5.44%
Revenue Next 5Y4.42%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLB Yearly Revenue VS EstimatesCLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
CLB Yearly EPS VS EstimatesCLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3

3

4. CLB Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 20.91 indicates a rather expensive valuation of CLB.
  • CLB's Price/Earnings ratio is a bit cheaper when compared to the industry. CLB is cheaper than 76.67% of the companies in the same industry.
  • CLB is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.79, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 21.07 indicates a rather expensive valuation of CLB.
  • CLB's Price/Forward Earnings ratio is in line with the industry average.
  • CLB is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.91
Fwd PE 21.07
CLB Price Earnings VS Forward Price EarningsCLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLB indicates a slightly more expensive valuation: CLB is more expensive than 66.67% of the companies listed in the same industry.
  • CLB's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 32.75
EV/EBITDA 11.2
CLB Per share dataCLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • CLB has a very decent profitability rating, which may justify a higher PE ratio.
  • CLB's earnings are expected to grow with 21.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.53%
EPS Next 3Y21.51%

3

5. CLB Dividend Analysis

5.1 Amount

  • CLB has a yearly dividend return of 0.25%, which is pretty low.
  • CLB's Dividend Yield is comparable with the industry average which is at 1.04.
  • Compared to an average S&P500 Dividend Yield of 1.91, CLB's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.25%

5.2 History

  • The dividend of CLB decreases each year by -32.16%.
  • CLB has paid a dividend for at least 10 years, which is a reliable track record.
  • CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-32.16%
Div Incr Years0
Div Non Decr Years3
CLB Yearly Dividends per shareCLB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • CLB pays out 5.88% of its income as dividend. This is a sustainable payout ratio.
DP5.88%
EPS Next 2Y2.53%
EPS Next 3Y21.51%
CLB Yearly Income VS Free CF VS DividendCLB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M
CLB Dividend Payout.CLB Dividend Payout, showing the Payout Ratio.CLB Dividend Payout.PayoutRetained Earnings

CLB Fundamentals: All Metrics, Ratios and Statistics

CORE LABORATORIES INC

NYSE:CLB (3/19/2026, 3:27:34 PM)

15.889

-0.17 (-1.06%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-04
Earnings (Next)N/A
Inst Owners109.8%
Inst Owner Change-0.67%
Ins Owners1.26%
Ins Owner Change7.43%
Market Cap739.79M
Revenue(TTM)526.52M
Net Income(TTM)31.80M
Analysts48
Price Target16.15 (1.64%)
Short Float %9.49%
Short Ratio11.11
Dividend
Industry RankSector Rank
Dividend Yield 0.25%
Yearly Dividend0.04
Dividend Growth(5Y)-32.16%
DP5.88%
Div Incr Years0
Div Non Decr Years3
Ex-Date02-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.53%
Min EPS beat(2)10.2%
Max EPS beat(2)12.86%
EPS beat(4)2
Avg EPS beat(4)4.52%
Min EPS beat(4)-4.67%
Max EPS beat(4)12.86%
EPS beat(8)5
Avg EPS beat(8)6.38%
EPS beat(12)7
Avg EPS beat(12)5.91%
EPS beat(16)9
Avg EPS beat(16)4.12%
Revenue beat(2)2
Avg Revenue beat(2)2.93%
Min Revenue beat(2)1.44%
Max Revenue beat(2)4.41%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)4.41%
Revenue beat(8)4
Avg Revenue beat(8)0.13%
Revenue beat(12)5
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.87%
PT rev (1m)0%
PT rev (3m)3.26%
EPS NQ rev (1m)-0.72%
EPS NQ rev (3m)31.43%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.73%
Valuation
Industry RankSector Rank
PE 20.91
Fwd PE 21.07
P/S 1.41
P/FCF 32.75
P/OCF 19.9
P/B 2.64
P/tB 12.55
EV/EBITDA 11.2
EPS(TTM)0.76
EY4.78%
EPS(NY)0.75
Fwd EY4.75%
FCF(TTM)0.49
FCFY3.05%
OCF(TTM)0.8
OCFY5.03%
SpS11.31
BVpS6.01
TBVpS1.27
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.14
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 11.37%
ROCE 12.23%
ROIC 8.59%
ROICexc 9.01%
ROICexgc 17.09%
OM 11.38%
PM (TTM) 6.04%
GM 20.69%
FCFM 4.29%
ROA(3y)5.63%
ROA(5y)4.73%
ROE(3y)13.38%
ROE(5y)12.66%
ROIC(3y)8.28%
ROIC(5y)7.52%
ROICexc(3y)8.61%
ROICexc(5y)7.81%
ROICexgc(3y)12.8%
ROICexgc(5y)11.12%
ROCE(3y)11.79%
ROCE(5y)10.71%
ROICexgc growth 3Y22.55%
ROICexgc growth 5Y6.53%
ROICexc growth 3Y8.12%
ROICexc growth 5Y-1.19%
OM growth 3Y6.08%
OM growth 5Y-2.63%
PM growth 3Y14.9%
PM growth 5YN/A
GM growth 3Y1.78%
GM growth 5Y-2.17%
F-Score7
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.88
Debt/EBITDA 1.48
Cap/Depr 99.59%
Cap/Sales 2.77%
Interest Coverage 250
Cash Conversion 49.87%
Profit Quality 71.02%
Current Ratio 2.07
Quick Ratio 1.57
Altman-Z N/A
F-Score7
WACC8.11%
ROIC/WACC1.06
Cap/Depr(3y)84.58%
Cap/Depr(5y)77.2%
Cap/Sales(3y)2.44%
Cap/Sales(5y)2.46%
Profit Quality(3y)82.62%
Profit Quality(5y)88.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.64%
EPS 3Y9.43%
EPS 5Y-0.77%
EPS Q2Q%-4.55%
EPS Next Y-0.77%
EPS Next 2Y2.53%
EPS Next 3Y21.51%
EPS Next 5Y20.48%
Revenue 1Y (TTM)0.51%
Revenue growth 3Y2.45%
Revenue growth 5Y1.56%
Sales Q2Q%6.98%
Revenue Next Year-0.76%
Revenue Next 2Y-0.67%
Revenue Next 3Y5.44%
Revenue Next 5Y4.42%
EBIT growth 1Y-1.42%
EBIT growth 3Y8.67%
EBIT growth 5Y-1.11%
EBIT Next Year33.61%
EBIT Next 3Y31.2%
EBIT Next 5Y23.36%
FCF growth 1Y-47.91%
FCF growth 3Y15.13%
FCF growth 5Y-13.26%
OCF growth 1Y-34.07%
OCF growth 3Y14.14%
OCF growth 5Y-8.48%

CORE LABORATORIES INC / CLB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CORE LABORATORIES INC?

ChartMill assigns a fundamental rating of 5 / 10 to CLB.


Can you provide the valuation status for CORE LABORATORIES INC?

ChartMill assigns a valuation rating of 3 / 10 to CORE LABORATORIES INC (CLB). This can be considered as Overvalued.


Can you provide the profitability details for CORE LABORATORIES INC?

CORE LABORATORIES INC (CLB) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CLB stock?

The Price/Earnings (PE) ratio for CORE LABORATORIES INC (CLB) is 20.91 and the Price/Book (PB) ratio is 2.64.


What is the expected EPS growth for CORE LABORATORIES INC (CLB) stock?

The Earnings per Share (EPS) of CORE LABORATORIES INC (CLB) is expected to decline by -0.77% in the next year.